The FBXW7-SHOC2-Raptor Axis Controls the Cross-Talks between the RAS-ERK and mTORC1 Signaling Pathways-Reference-Cited by-同舟云学术

The FBXW7-SHOC2-Raptor Axis Controls the Cross-Talks between the RAS-ERK and mTORC1 Signaling Pathways

Published:2019-03 Issue:11 Volume:26 Page:3037-3050.e4
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Xie Chuan-Ming,Tan Mingjia,Lin Xiao-Tong,Wu Di,Jiang Yihan,Tan Ye,Li Haomin,Ma Yuanyuan,Xiong Xiufang,Sun Yi

Funder

National Key R&D Program

National Natural Science Foundation of China

NCI

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference53 articles.

1. Combined gene expression analysis of whole-tissue and microdissected pancreatic ductal adenocarcinoma identifies genes specifically overexpressed in tumor epithelia;Badea;Hepatogastroenterology,2008

2. Targeted deep sequencing of circulating tumor DNA in metastatic pancreatic cancer;Berger;Oncotarget,2017

3. Pin1 stabilizes Emi1 during G2 phase by preventing its association with SCF(betatrcp);Bernis;EMBO Rep.,2007

4. The TOR signaling cascade regulates gene expression in response to nutrients;Cardenas;Genes Dev.,1999

5. Oncogenic MAPK signaling stimulates mTORC1 activity by promoting RSK-mediated raptor phosphorylation;Carrière;Curr. Biol.,2008

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The expression of congenital Shoc2 variants induces AKT-dependent crosstalk activation of the ERK1/2 pathway;Human Molecular Genetics;2024-06-17

2. SHOC2 plays an oncogenic or tumor-suppressive role by differentially targeting the MAPK and mTORC1 signals in liver cancer;Life Medicine;2024-05-23

3. Exploiting bacterial effector proteins to uncover evolutionarily conserved antiviral host machinery;PLOS Pathogens;2024-05-16

4. The interplay between autophagy and ferroptosis presents a novel conceptual therapeutic framework for neuroendocrine prostate cancer;Pharmacological Research;2024-05

5. Epidermal growth factor receptor (EGFR) is a target of the tumor-suppressor E3 ligase FBXW7;Proceedings of the National Academy of Sciences;2024-03-14